HCL Technologies Limited
Quality (73/100) does the heavy lifting; valuation (36/100) is the drag.
Buy zoneOvervaluedHCL Technologies Limited earns a Hold from StocksWizard, with a blended score of 45/100. At ₹1,344.3 it trades above our blended DCF and relative-multiples fair value of ₹884.79, about 34% downside to that estimate — we read it as overvalued by 34%. On 18.2x trailing earnings it sits roughly in line with the Technology median of about 20.0x. The price is about 20% below its 52-week high of ₹1,679.96 and 31% above the low of ₹1,023.75. Financial health scores 100/100, in the safe band on the Altman Z-score, with a Piotroski F-score of 6/9. The average analyst target of ₹1,419.75 implies about 6% upside across 40 analysts. It clears 7 of 13 investability checks, with durability 73, valuation 71 and momentum 55 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹707.83. Low-confidence estimate — limited data.
Analyst views
1-year price
EOD · 2026-07-2952-week range
-19.98% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Hold45Piotroski F-score 6/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Pass: ROE above 15%: 23.4%
- Pass: Low debt (D/E < 0.5): 0.07x
- Pass: Positive free cash flow
- Fail: Revenue growth > 10%: 5%
- Fail: Earnings growing: -0%
- Pass: Net margin ≥ 10%: 12.8%
- Pass: Current ratio > 1.5: 2.22
- Fail: Below our fair value
- Fail: Margin of safety ≥ 20%
- Fail: Above 200-day average
- Pass: Above 50-day average
- No data: Positive 1-year return
- Pass: Altman Z in safe zone: Z 6.61
- Fail: Piotroski ≥ 7: 6/9
Quarterly results
Annual financials
Shareholding
- Promoter62.8%
- Institutions28.5%
- Public & other8.7%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Strengths
- Strong return on equity (23.4%).
- Lightly leveraged balance sheet.
- Financially solid — Altman Z 6.61.
Opportunities
- Trading in our value buy zone versus sector peers.
Bear case
Weaknesses
- Price below its 200-day moving average (downtrend).
Threats
- Earnings contracting year on year.
- Trades ~34% above our estimated fair value.
About HCL Technologies Limited
HCL Technologies Limited provides IT and business services, engineering, research and development services, software products, and IP-led offerings. It operates through IT and Business Services, Engineering and R&D Services, and HCL Software segments. The company provides application development, management, modernization, and testing services, as well as commercial applications; automation services, including digital integration, business process management, robotic process
HCL Technologies Limited — frequently asked questions
Is HCL Technologies Limited a buy, hold or sell?
StocksWizard currently rates HCL Technologies Limited (HCLTECH) a Hold, based on a blended score of 45/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is HCL Technologies Limited's fair value?
Our blended DCF and relative-valuation model estimates HCL Technologies Limited's fair value at about ₹884.79, versus a current price of ₹1,344.3 — roughly 34% downside. On that basis the stock looks overvalued by 34%.
Is HCL Technologies Limited financially healthy?
HCL Technologies Limited scores 100/100 on our financial-health model, placing it in the safe band on the Altman Z-score, with a Piotroski F-score of 6/9.
How has HCL Technologies Limited's share price performed?
HCL Technologies Limited is up 13% over three months, and last traded at ₹1,344.3. Past performance doesn't predict future returns.
More in Technology
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.